• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Life Sciences And Biotechnology For Turkey
 

Life Sciences And Biotechnology For Turkey

on

  • 1,964 views

 

Statistics

Views

Total Views
1,964
Views on SlideShare
1,957
Embed Views
7

Actions

Likes
1
Downloads
70
Comments
0

1 Embed 7

http://www.linkedin.com 7

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Life Sciences And Biotechnology For Turkey Life Sciences And Biotechnology For Turkey Presentation Transcript

    • LIFE SCIENCES AND BIOTECHNOLOGY HOW WE CAN START
    • LIFE SCIENCES AND BIOTECHNOLOGY
      • THE STRATEGIC CHALANGES
      • RECOGNIZED NEW TECHNOLOGY
      • NEXT WAVE OF THE KNOWLEDGE-BASED TECHNOLOGY
      • CREATE NEW OPPORTUNITIES
      • REQURE NEW POLICIES
      • ADVANTAGE FOR
      • ECONOMIES; FINANCIAL BENEFIT
      • SOCIETIES; HEALTH, AGING, FOOD, ENVIRONMENT
    • Deal making for Growth: How Biotech Firms Can Avoid the Tragedy of "Boom and Bust"
      • "Biotech firms, once the darlings of the investment community, today find themselves between a rock and a hard place when it comes to accessing the resources necessary to grow."
    • Main conclusions:
      • Of over 300 biotech companies, less than a dozen have truly succeeded in the last 12 years. The high failure rate has left investors leery, making it tougher than ever for biotechs to obtain funding and survive long enough to bring a product successfully to the market.
      • Many biotechs are merging in the hope that their joint knowledge and financial resources can keep them afloat. However, few investors are likely to believe that two sinking vessels can become an agile battleship just by linking up.
    • According to McKinsey deals between pharmaceutical companies and biotechs can be mutually beneficial:
      • Biotech companies lack direct access to end customers,
      • While pharma companies need the knowledge and technologies that biotechs provide.
      • The key to success for biotechs then lies in the creation of balanced portfolios that are comprised of three types of licensing deals
      • Product deals
      • Pre-product deals
      • Information and technology deals
    • Three types of deals
      • ALL have different cash flow profiles,
      • ALL are needed to ensure a steady inflow of financial resources.
      • Besides increasing the company's net present value, the perceived lower uncertainty of the business is directly rewarded by investors with higher stock prices.
    • The modern biotechnology industry
      • The modern biotechnology industry is a group of companies making different kinds of products, but all using biotechnology tools. Some of these companies start up as small research groups seeking to create a new technology or solve a new problem using biotechnology; others are large multinational corporations in traditional industries, such as those producing pharmaceuticals, that adopt the tools of biotechnology to advance their research or improve their production processes. 
    • Biotechnology
      • Traditional definition: Biotechnology is the use of living organisms to solve problems and make useful products. Domesticating crop plants and farm animals through selective breeding, and using yeast to make bread rise and produce wine are examples of traditional biotechnology.
    • Biotechnology
      • Newer definition: Biotechnology is the use of living cells and their molecules to solve problems and make useful products. Scientific advances over the last 50 years have enabled us to understand how living organisms work—and how they can work for us. The key knowledge is an understanding of cells, the basic units of life, and—at a still deeper level—the molecules that make up cells.
    • – G. Steven Burrill, Biotech 2003 (Life Sciences: Revaluation and Restructuring)
      • "...it is important to remember that biotech is the one industry that's poised to grapple with every major human and environmental challenge, from global hunger to global warming..."
    • The applications of biotechnology
      • are far-reaching—
      • Biofuels : Renewable energy produced from organic matter.
      • Biomanufacturing : The creation of biological products from living cells.
      • Bio and Agro-Defense
      • Human Health
      • Agricultural : Everything from herbicide- and insect-resistant crops to biofuels.
      • Environmental : Biotechnology is used to preserve nature.
      • Industrial : Biotechnology is used to create products and solve problems in many other industries.
      • Genomics and Bioinformatics: Genomics is the study of all the genes in an organism, also known as its genome. .
    • Human Health
      • Therapy Products
      • Diagnostic Tests
      • Plant-Based Medicines
    • Therapy Products
      • Vaccines are being developed against cancer, rabies, malaria and many other diseases, with the help of biotechnology tools.
      • Biotechnology techniques are used to develop and manufacture therapeutic proteins , insulin and blood-clotting factors.
    • Diagnostic Tests
      • Rapid and cost-effective diagnostic tests for strep throat, cancer and high cholesterol have been developed with the use of biotechnology. Early diagnosis of these and other diseases leads to earlier and more effective treatment.
      • Genetic tests can warn of potential diseases, such as diabetes, cancer and asthma so therapies can begin as early as possible.
      • Physician researchers in North Carolina are also reporting major advances in using biotechnology capabilities to adapt animal organs for human use and even growing organs from donors’ own cells.
    • Plant-Based Medicines
      • Thanks to biotechnology, even plants can now be engineered to produce large quantities of vaccines and other biologics for health care uses.
      • make complex proteins and monoclonal antibodies.
      • market a rice-produced protein that would be added to oral-rehydration solutions to combat diarrhea.
    • New Drugs To Watch Matthew Herper and Robert Langreth, NEW YORK -
      • Pharmaceutical and biotechnology companies are literally developing hundreds of medicines.
      • Cardiovascular Disease
      • Cancer
      • Diabetes
      • Neurological Disease
      • Others, Allergy, Dermatology etc.